Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Population

Intervention or exposure

Comparison

Outcome

Any field or review title

Field or topic

Source

Review versions

135 questions in 34 reviews · Infectious Diseases

current versions

No studies 135 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Question	Effect	Evidence	Status / GRADE
Oral iron vs placebo or no treatment Subgroup · children in malaria‐endemic areas Oral iron supplements for children in malaria‐endemic areas (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Subgroup · children in malaria‐endemic areas Oral iron supplements for children in malaria‐endemic areas (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Test result GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Test result GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Test result GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Severe adverse events11 · Pregnant women (parity 2+) Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no… (2014) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Severe adverse effects12 · Pregnant women (parity 0‐1) Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no… (2014) · Cochrane	no estimate extracted	NR	No studies
Intervention NR CI: confidence interval · Patients suspected to have visceral leishmaniasis disease 1 Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease (2014) · Cochrane	no estimate extracted	NR	No studies
Intervention NR CI: confidence interval · Patients suspected to have visceral leishmaniasis disease 1 Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease (2014) · Cochrane	no estimate extracted	NR	No studies
Intervention NR CI: confidence interval · Patients suspected to have visceral leishmaniasis disease 1 Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease (2014) · Cochrane	no estimate extracted	NR	No studies
Probiotic vs placebo Death from any cause ‐ not measured · Children with persistent diarrhoea Probiotics for treating persistent diarrhoea in children (2013) · Cochrane	no estimate extracted	NR	No studies
Probiotic vs placebo Weight‐for‐age z score ‐ not measured · Children with persistent diarrhoea Probiotics for treating persistent diarrhoea in children (2013) · Cochrane	no estimate extracted	NR	No studies
Antipyretic drugs vs no antipyretic drug or placebo Adverse Events · patients with fever in malaria Antipyretic measures for treating fever in malaria (2012) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Neurological sequelae at day 28 · Adults with severe malaria Artesunate versus quinine for treating severe malaria (2012) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Major neurological sequelae · Children aged 6‐60 months with cerebral malaria Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria (2011) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Time to hospital discharge · Children aged 6‐60 months with cerebral malaria Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria (2011) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Need for ventilation · Children aged 6‐60 months with cerebral malaria Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria (2011) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Need for cardiopulmonary resuscitation · Children aged 6‐60 months with cerebral malaria Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria (2011) · Cochrane	no estimate extracted	NR	No studies
Fluoroquinolones vs macrolides Relapse ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Fluoroquinolones vs macrolides Serious adverse events ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Cotrimoxazole vs beta‐lactams Relapse ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Cotrimoxazole vs beta‐lactams Serious adverse events ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Cotrimoxazole vs fluoroquinolones (norfloxacin) Diarrhoea on · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Cotrimoxazole vs fluoroquinolones (norfloxacin) Relapse ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Cotrimoxazole vs fluoroquinolones (norfloxacin) Serious adverse events ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Cotrimoxazole vs furazolidone Relapse ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Cotrimoxazole vs furazolidone Other adverse events ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Oral gentamicin vs nalidixic acid Relapse ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Oral gentamicin vs nalidixic acid Serious adverse events ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Antibiotic vs no drug or placebo Relapse ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Oral gentamicin vs nalidixic acid Other adverse events ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Sulphonamides vs tetracycline Relapse ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Sulphonamides vs tetracycline Serious adverse events ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Sulphonamides vs tetracycline Other adverse events ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies
Antibiotic vs no drug or placebo Serious adverse events ‐ not reported · patients with Shigella dysentery Antibiotic therapy for Shigella dysentery (2010) · Cochrane	no estimate extracted	NR	No studies